# Natalie S. Callander

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/natalie-s-callander/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,364 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 62 |
| i10-index | 171 |
| Last Known Institution | University of Wisconsin Carbone Cancer Center |
| OpenAlex ID | https://openalex.org/A5042432109 |
| ORCID iD | https://orcid.org/0000-0002-6975-1086 |
| Works | 445 |

## Researcher papers

- [Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study](https://scholariq.org/papers/belantamab-mafodotin-for-relapsed-or-refractory-multiple-myeloma-dreamm-2-a-two/)
- [Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/ide-cel-or-standard-regimens-in-relapsed-and-refractory-multiple-myeloma/)
- [Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial](https://scholariq.org/papers/carfilzomib-or-bortezomib-in-combination-with-lenalidomide-and-dexamethasone-for/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)

## Researcher university

- [University of Wisconsin Carbone Cancer Center](https://scholariq.org/institutions/university-of-wisconsin-carbone-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.